165 related articles for article (PubMed ID: 38661098)
1. Evaluation of the preoperative neutrophil-to-lymphocyte ratio as a predictor of the micropapillary component of stage IA lung adenocarcinoma.
Chen C; Chen ZJ; Li WJ; Deng T; Le HB; Zhang YK; Zhang BJ
J Int Med Res; 2024 Apr; 52(4):3000605241245016. PubMed ID: 38661098
[TBL] [Abstract][Full Text] [Related]
2. Does the presence of a micropapillary component predict worse prognosis in pathological stage IA lung adenocarcinoma?
Wang Y; Song W; Wang X; Che G
Pathol Res Pract; 2023 Feb; 242():154314. PubMed ID: 36706587
[TBL] [Abstract][Full Text] [Related]
3. Micropapillary and/or Solid Histologic Subtype Based on Pre-Treatment Biopsy Predicts Local Recurrence After Thermal Ablation of Lung Adenocarcinoma.
Gao S; Stein S; Petre EN; Shady W; Durack JC; Ridge C; Adusumilli P; Rekhtman N; Solomon SB; Ziv E
Cardiovasc Intervent Radiol; 2018 Feb; 41(2):253-259. PubMed ID: 28770314
[TBL] [Abstract][Full Text] [Related]
4. A prognostic nomogram based on a new classification of combined micropapillary and solid components for stage IA invasive lung adenocarcinoma.
Huang W; Zhang H; Zhang Z; Zhang B; Sun X; Huo Y; Feng Y; Tian P; Mo H; Wang C
J Surg Oncol; 2022 Mar; 125(4):796-808. PubMed ID: 34862621
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients.
Yamauchi Y; Safi S; Muley T; Warth A; Herth FJF; Dienemann H; Hoffmann H; Eichhorn ME
Lung Cancer; 2017 Dec; 114():62-67. PubMed ID: 29173768
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of the preoperative lymphocyte-to-monocyte ratio for survival after lung cancer surgery.
Ramos R; Macía I; Navarro-Martin A; Déniz C; Rivas F; Ureña A; Masuet-Aumatell C; Moreno C; Nadal E; Escobar I
BMC Pulm Med; 2021 Mar; 21(1):75. PubMed ID: 33653309
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of tumor spread through air spaces in patients with stage IA part-solid lung adenocarcinoma after sublobar resection.
Chae M; Jeon JH; Chung JH; Lee SY; Hwang WJ; Jung W; Hwang Y; Cho S; Kim K; Jheon S
Lung Cancer; 2021 Feb; 152():21-26. PubMed ID: 33338924
[TBL] [Abstract][Full Text] [Related]
8. Micropapillary or solid component predicts worse prognosis in pathological IA stage lung adenocarcinoma: A meta-analysis.
Wang Y; Hu J; Sun Y; Lu Y
Medicine (Baltimore); 2023 Dec; 102(49):e36503. PubMed ID: 38065873
[TBL] [Abstract][Full Text] [Related]
9. Impact of minimal solid and micropapillary components on invasive lung adenocarcinoma recurrence.
Chen C; Chen ZJ; Li WJ; Pan XF; Wen YY; Deng T; Le HB; Zhang YK; Zhang BJ
Ann Diagn Pathol; 2022 Aug; 59():151945. PubMed ID: 35397312
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of pretreatment inflammatory biomarkers in advanced lung adenocarcinoma patients receiving first-line pemetrexed/platinum doublet.
Xiong Y; Zhao N; Zheng Y; Wang J; Wei F; Ren X
Tumour Biol; 2017 Jun; 39(6):1010428317701639. PubMed ID: 28618954
[TBL] [Abstract][Full Text] [Related]
11. Novel method for rapid identification of micropapillary or solid components in early-stage lung adenocarcinoma.
Zhao ZR; Lau RWH; Long H; Mok TSK; Chen GG; Underwood MJ; Ng CSH
J Thorac Cardiovasc Surg; 2018 Dec; 156(6):2310-2318.e2. PubMed ID: 30180981
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance and survival benefits of postoperative adjuvant chemotherapy in patients with stage IA lung adenocarcinoma with non-predominant micropapillary components.
Li R; Qiu J; Li Z; Li H; Tang Z; Yu W; Tian H; Sun Z
World J Surg Oncol; 2024 Jan; 22(1):32. PubMed ID: 38273367
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma.
Qian F; Yang W; Wang R; Xu J; Wang S; Zhang Y; Jin B; Yu K; Han B
J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1227-1235.e2. PubMed ID: 29223834
[TBL] [Abstract][Full Text] [Related]
14. Micropapillary histological subtype in lung adenocarcinoma of 2 cm or less: impact on recurrence and clinical predictors.
Yoshida Y; Nitadori JI; Shinozaki-Ushiku A; Sato J; Miyaji T; Yamaguchi T; Fukayama M; Nakajima J
Gen Thorac Cardiovasc Surg; 2017 May; 65(5):273-279. PubMed ID: 28243892
[TBL] [Abstract][Full Text] [Related]
15. Significant difference in recurrence according to the proportion of high grade patterns in stage IA lung adenocarcinoma.
Jeon HW; Kim YD; Sim SB; Moon MH
Thorac Cancer; 2021 Jul; 12(13):1952-1958. PubMed ID: 34037324
[TBL] [Abstract][Full Text] [Related]
16. Intense Expression of EGFR L858R Characterizes the Micropapillary Component and L858R Is Associated with the Risk of Recurrence in pN0M0 Lung Adenocarcinoma with the Micropapillary Component.
Kishi N; Ito M; Miyata Y; Kanai A; Handa Y; Tsutani Y; Kushitani K; Takeshima Y; Okada M
Ann Surg Oncol; 2020 Mar; 27(3):945-955. PubMed ID: 31732945
[TBL] [Abstract][Full Text] [Related]
17. Complete Blood Cell Count-Derived Inflammatory Biomarkers in Early-Stage Non-Small-Cell Lung Cancer.
Shoji F; Kozuma Y; Toyokawa G; Yamazaki K; Takeo S
Ann Thorac Cardiovasc Surg; 2020 Oct; 26(5):248-255. PubMed ID: 32074540
[TBL] [Abstract][Full Text] [Related]
18. Cryobiopsy as a reliable technique for the preoperative identification of micropapillary/solid components in early-stage lung adenocarcinoma.
Suzuki M; Matsumoto Y; Imabayashi T; Teishikata T; Tsuchida T; Asamura H; Yatabe Y
Lung Cancer; 2021 Dec; 162():147-153. PubMed ID: 34814012
[TBL] [Abstract][Full Text] [Related]
19. Radiologic Predictors for Clinical Stage IA Lung Adenocarcinoma with Ground Glass Components: A Multi-Center Study of Long-Term Outcomes.
Li Z; Ye B; Bao M; Xu B; Chen Q; Liu S; Han Y; Peng M; Lin Z; Li J; Zhu W; Lin Q; Xiong L
PLoS One; 2015; 10(9):e0136616. PubMed ID: 26339917
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
